Similar encouraging results were found by comparison between Tf-modified PTX NCs (Tf-PTX-NC) and PTX NCs in human breast cancer cell line MCF-7, and additionally, Tf-PTX-NCs had lower toxicity in immortalized human keratinocyte cell line HaCaT, indicating benefits in both efficacy and safety [98]. This evidence concerns the gene TF and breast cancer.